Lyell Immunopharma
LYEL
#7656
Rank
โ‚น21.62 B
Marketcap
โ‚น77.45
Share price
-11.01%
Change (1 day)
-47.50%
Change (1 year)

Lyell Immunopharma (LYEL) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น37.22 Billion

According to Lyell Immunopharma's latest financial reports the company has โ‚น37.22 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lyell Immunopharma - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น45.47 B-14.16%
2022-12-31โ‚น52.97 B15.76%
2021-12-31โ‚น45.75 B2.14%
2020-12-31โ‚น44.80 B44.08%
2019-12-31โ‚น31.09 B